1. Combing metabolomics with bioanalysis methods to study the antitumor mechanism of the new acridone derivative 8q on CCRF-CEM cells: 8q induced mitochondrial-mediated apoptosis and targeted the PI3K/AKT/FOXO1 pathway
   Ning Wang et al, 2018, Journal of Pharmaceutical and Biomedical Analysis CrossRef
2. Use of ratiometrically designed nanocarrier targeting CDK4/6 and autophagy pathways for effective pancreatic cancer treatment
   Ying Ji et al, 2020, Nature Communications CrossRef
3. Electrochemotherapy with Irreversible Electroporation and FOLFIRINOX Improves Survival in Murine Models of Pancreatic Adenocarcinoma
   Neal Bhutiani et al, 2020, Annals of Surgical Oncology CrossRef
4. Overcoming Gemcitabine Resistance in Pancreatic Cancer Using the BCL-XL–Specific Degrader DT2216
   Dinesh Thummuri et al, 2022, Molecular Cancer Therapeutics CrossRef
5. Sensitivity of pancreatic cancer cells to chemotherapeutic drugs, signal transduction inhibitors and nutraceuticals can be regulated by WT-TP53
   Stephen L. Abrams et al, 2021, Advances in Biological Regulation CrossRef
6. PROTACs in gastrointestinal cancers
   Yu Chen et al, 2022, Molecular Therapy - Oncolytics CrossRef
7. Mitochondrial targeting of TR3 is involved in TPA induced apoptosis in breast cancer cells
   Caineng Zhong et al, 2019, Gene CrossRef
8. Transcriptome analysis of iBET-151, a BET inhibitor alone and in combination with paclitaxel in gastric cancer cells
   Sun Kyoung Kang et al, 2020, Genomics & Informatics CrossRef
9. 1-MT grafted carboxymethyl chitosan and its nanoparticles: Preparation, characterization and evaluation
   Jiaming Li et al, 2021, European Journal of Pharmaceutical Sciences CrossRef
10. Pharmacodynamic modeling of synergistic birinapant/paclitaxel interactions in pancreatic cancer cells
    Jin Niu et al, 2020, BMC Cancer CrossRef
11. Emerging biomarkers and potential therapeutics of the BCL-2 protein family: the apoptotic and anti-apoptotic context
    Md. Saddam et al, 2024, Egyptian Journal of Medical Human Genetics CrossRef
12. Small molecule inhibitors in pancreatic cancer
    Jufeng Sun et al, 2020, RSC Medicinal Chemistry CrossRef
13. Paclitaxel and docetaxel resistance in prostate cancer: Molecular mechanisms and possible therapeutic strategies
    Mehrdad Hashemi et al, 2023, Biomedicine & Pharmacotherapy CrossRef
14. Chemoresistance to Cancer Treatment: Benzo-α-Pyrene as Friend or Foe?
    Kevin Dzobo et al, 2018, Molecules CrossRef
15. Recent Developments and Anticancer Therapeutics of Paclitaxel: An Update
    Muthu Thiruvengadam et al, 2022, Current Pharmaceutical Design CrossRef
16. Molecular Research in Pancreatic Cancer: Small Molecule Inhibitors, Their Mechanistic Pathways and Beyond
    Shaila A. Shetu et al, 2023, Current Issues in Molecular Biology CrossRef
17. Taxol (Paclitaxel): A Novel Alkaloid with Anticancer Potential
    Abdur Rauf et al, 2024, International Journal of Pharmaceutical And Phytopharmacological Research CrossRef
18. Programmed cell death, redox imbalance, and cancer therapeutics
    Xiaofeng Dai et al, 2021, Apoptosis CrossRef
19. Mechanisms of cancer cell death induction by paclitaxel: an updated review
    Shuang Zhao et al, 2022, Apoptosis CrossRef